Bakgrunn og aktiviteter
Stein Kaasa is Professor of Palliative Medicine at the Institute of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim (NTNU). His responsibilities include the development of the core curriculum in palliative medicine and the development of the Nordic specialist postgraduate training curriculum in palliative medicine. Professor Kaasa’s main research interests are: basic research in assessment and classification of symptoms and subjective health; experimental and descriptive clinical studies in palliative medicine and cancer research; pain treatment including translational research on opioids and on cachexia.
Professor Kaasa has published more than 400 articles and book chapters. He has authored the Nordic Textbook of Palliative Care and is co-author of the Oxford Textbook of Palliative Medicine. Professor Kaasa advises many international journals – either as an advisory board member or as a reviewer (Journal of Pain and Symptom Management, Palliative Medicine, Journal of Palliative Medicine, Oncology, Journal of Clinical Oncology, Pain, Lancet Oncology).
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
- (2016) The Edmonton Symptom Assessment System: Poor performance as a screener for major depression in patients With incurable cancer. Palliative Medicine : A Multiprofessional Journal. vol. 30 (6).
- (2016) Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Critical reviews in oncology/hematology. vol. 99.
- (2016) Eir, a computerized tool for symptom management and decision support in cancer care. European Journal of Palliative Care.
- (2015) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica. vol. 54 (3).
- (2015) Innate immune signalling genetics of pain, cognitive dysfunction and sickness symptoms in cancer pain patients treated with transdermal fentanyl. PLoS ONE. vol. 10:0137179 (9).
- (2015) Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?. BMJ Open. vol. 5 (5).
- (2015) Reduction in tumor size after the first course of cisplatin/etoposide (PE) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology. vol. 33.
- (2015) Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC). Journal of Thoracic Oncology. vol. 10 (9).
- (2015) Indicators of integration of oncology and palliative care programs: An international consensus. Annals of Oncology. vol. 26 (9).
- (2015) Integration of Oncology and Palliative Care: A Systematic Review. The Oncologist. vol. 20 (1).
- (2015) Depressive symptoms in the last days of life of patients with cancer: a nationwide retrospective mortality study. BMJ Supportive & Palliative Care.
- (2015) Renal function and symptoms/adverse effects in opioid-treated patients with cancer. Acta Anaesthesiologica Scandinavica. vol. 59 (8).
- (2015) Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids. Clinical and Translational Gastroenterology. vol. 6:e90.
- (2015) Depression in advanced cancer - Assessment challenges and associations with disease load. Journal of Affective Disorders. vol. 173.
- (2015) Symptom clusters in people living with HIV attending five palliative care facilities in two sub-Saharan African countries: A hierarchical cluster analysis. PLoS ONE. vol. 10:e0126554 (5).
- (2015) Development of an item bank for computerized adaptive test (CAT) measurement of pain. Quality of Life Research. vol. 25.
- (2015) Place of death in the population dying from diseases indicative of palliative care need: A cross-national population-level study in 14 countries. Journal of Epidemiology and Community Health. vol. 70 (1).
- (2015) Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncologica. vol. 54 (3).
- (2015) The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Annals of Oncology. vol. 27 (2).
- (2015) Efficacy and Tolerability of Intranasal Fentanyl Spray in Cancer Patients with Breakthrough Pain. Clinical Therapeutics. vol. 37 (3).